This Is MS Multiple Sclerosis Knowledge & Support Community

Drug-Induced Liver Injury Becomes More Prevalent Thu, 06/27/2013 - 10:45am More people are being affected by drug-induced liver injury (DILI) than ever before, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. This type of liver injur...

http://www.medpagetoday.com/MeetingCoverage/CMSC-ACTRIMS/39495 Goat Serum Extract Stops Progressive MS By John Gever, Deputy Managing Editor, MedPage Today Published: May 31, 2013 Reviewed by F. Perry Wilson, MD, MSCE; Instructor of Medicine, Perelman School of Medicine at the University of Pennsylv...

http://opinionator.blogs.nytimes.com/2011/05/02/helping-new-drugs-out-of-academias-valley-of-death/ May 2, 2011, 9:15 pm Helping New Drugs Out of Research’s ‘Valley of Death’ Consider two numbers: 800,000 and 21. The first is the number of medical research papers that were published in 2008. The sec...

AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

Clinical trial still going:

http://clinicaltrials.gov/ct2/show/NCT01228396

Looks like they may be making changes to the protocol.

At least it is moving along

New Discoveries Could Lead to MS Treatment Drug Discovery & Development - October 22, 2010 Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) – a finding that could have important implica...

http://www.dddmag.com/news-Court-Ruling-Could-Hamper-Drug-Innovation-030409.aspx Court Ruling Could Hamper Drug Innovation Linda A. Johnson, AP Business Writer Drug Discovery & Development - March 04, 2009 (AP) - A US Supreme Court ruling that federal approval of a drug is no protection from law...

Sorry about the size. http://www.nytimes.com/2009/03/03/business/03medschool.html?_r=2&em Harvard Medical School in Ethics Quandary By DUFF WILSON Published: March 2, 2009 BOSTON — In a first-year pharmacology class at Harvard Medical School, Matt Zerden grew wary as the professor promoted the b...

Has anyone seen this or can shed some light on it? http://immunosyn.wordpress.com/2008/09/19/is-immunosyn-imynob-and-sf-1019-for-real-you-decide/ Patent infringement? I am a stockholder of Immunosyn and are angry at the without substance posts, both here and on other boards about the alleged patent ...

http://www.nbr.co.nz/article/virionyx-director-usa-taps-investors-further-capital-38222 This company were originally working with a treatment for HIV. I found this Virionyx director in USA taps investors for further capital NZPA | Monday November 24 2008 - 07:37pm An American director of Virionyx, a...

Whilst surfing today I found this snippet in the latest Immunosyn Corporation filings to the SEC. http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=6254266 A Physician Sponsored IND Application to the Food and Drug Administration in the U.S. for a Phase II Clinical Trial for Multiple Sclerosis ...

http://news.bbc.co.uk/1/hi/health/7715224.stm Looks like a bit of a push going on here. Patient groups have launched a campaign to warn people against trying untested remedies. Many of the organisations believe that misleading information on the internet is leading to an increase in the number of vu...

10 Nov 2008 The MS Society has today joined forces with charitable trust Sense About Science as part of an initiative to highlight the importance of evidence-based information on new treatments and therapies. A guide published today entitled ‘I’ve got nothing to lose by trying it’ explains how to te...

http://www.timesonline.co.uk/tol/life_and_style/health/article4996181.ece New drug raises hope of reversing multiple sclerosis in early stages Mark Henderson, Science Editor A step change in the treatment of multiple sclerosis is heralded today by the first study to suggest that a drug can stop the ...

I was sent this today and although it refers to Diabetes etc and not specifically MS, the bit about inflammation is interesting NOTE: The marketing name change to R-1818 for Malaysia +++++++++ Immunosyn Corporation receives full regulatory approval to market SF-1019 in Malaysia Aug 13, 2008 (M2 EQUI...

They do not seem to have released the article yet, but here are some links to the BBC website and their programmes on MS BBC journalist Elizabeth Quigley gives an insight into her life with Multiple Sclerosis as part of her investigation into why the disease is so common in Scotland. http://news.bbc...